Skip to main content

Table 2 Logistic regression analysis of predictor for csPC

From: A comparative study of transperineal software-assisted magnetic resonance/ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostate

 

Univariate

Multivariate

OR

95% CI

p

OR

95% CI

p

Age

1.06

1.02–1.1

0.003

1.05

1.01–1.1

0.023

Prior negative biopsy

0.62

0.32–1.19

0.149

   

DRE

      

 Negative

reference

     

 Positive

0.58

0.31–1.09

0.089

   

PSA

1.04

1.00–1.08

0.055

1.03

0.99–1.06

0.111

PI-RADS

      

 3

reference

     

 > 3

5.25

1.72–16.02

0.004

5.99

1.72–20.84

0.005

Number of total cores

1.03

0.98–1.09

0.276

   

Biopsy route

      

 Transperineal

1.99

1.09–3.63

0.026

2.55

1.32–4.95

0.006

 Transrectal

Reference

     

Target lesion location

      

 Posterior

Reference

     

 Anterior

2.02

1.09–3.74

0.026

1.81

0.91–3.57

0.09

  1. CI: confidence interval; csPC: clinically significant prostate cancer; DRE: digital rectal exam; OR: odds ratio; PSA: prostate specific antigen; PI-RADS: Prostate Imaging Reporting & Data System